Leading Researcher to Join National Pharmaceutical Council as Chief Science Officer

Oct 18, 2010, 10:36 ET from National Pharmaceutical Council

Dr. Robert Dubois to Head NPC's Research Programs

WASHINGTON, Oct. 18 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Robert W. Dubois, MD, PhD, is joining the organization as its chief science officer. In this role, he will oversee NPC's research on health policy issues related to evidence-based medicine, comparative effectiveness review and the value of improved health outcomes.  

"NPC is focused on research and education that will help inform the development, understanding and use of comparative evidence by health care decision makers," said NPC President Dan Leonard. "Given Dr. Dubois' experience in developing research that is both pragmatic and scientifically sound, we're excited about the opportunity to work with him as we continue to grow NPC's research portfolio.  As NPC increases its focus on health care reform and the Patient-Centered Outcomes Research Institute (PCORI), Dr. Dubois' expertise will enhance our contributions to evidence-based medicine and comparative effectiveness research development."

Dr. Dubois, who is board certified in internal medicine, brings a unique blend of experiences to his new role. Previously, he was the chief medical officer at Cerner LifeSciences, where he focused on comparative effectiveness and the use of an electronic health records infrastructure to implement clinical change.  

Prior to joining Cerner in 2001, Dr. Dubois co-founded Protocare Sciences and was its executive vice president, chief medical officer, and later its chief executive officer.  

Throughout his career, Dr. Dubois' primary interest has centered on defining "what works" in health care and finding ways for that evidence to inform health care decision making. He also is a recognized expert in the areas of defining best practice, disease management and appropriateness of care, and has authored more than 100 peer-reviewed articles on comparative effectiveness, evidence-based medicine, the development of practice guidelines, and determining the optimal use of high cost medical services. Additionally, Dr. Dubois was the lead author on the NPC publication, "Demystifying Comparative Effectiveness Research: A Case Study Learning Guide," which explains the three most common types of comparative effectiveness studies and their respective strengths for health care decision making.  

Dr. Dubois received his AB from Harvard College, his MD from the Johns Hopkins School of Medicine and his PhD in Health Policy from the RAND Graduate School.  He also trained as a Robert Wood Johnson Clinical Scholar and completed a Post-Doctoral Fellowship with the RAND Corporation.

About the National Pharmaceutical Council

NPC's overarching mission is to sponsor and conduct scientific analyses of the appropriate use of biopharmaceuticals and the clinical and economic value of innovation. The organization's strategic focus is on evidence-based medicine (EBM) for health care decision-making, to ensure that patients have access to high-quality care. NPC was established in 1953 and is supported by the nation's major research-based pharmaceutical companies. For more information, visit www.npcnow.org.

SOURCE National Pharmaceutical Council



RELATED LINKS

http://www.npcnow.org